REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 91 filers reported holding REVOLUTION MEDICINES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,029,418 | +8.6% | 145,572 | +5.0% | 0.01% | +25.0% |
Q2 2023 | $3,709,636 | +128261.1% | 138,678 | +3.9% | 0.00% | 0.0% |
Q1 2023 | $2,890 | +2.2% | 133,415 | +12.4% | 0.00% | 0.0% |
Q4 2022 | $2,828 | -99.9% | 118,737 | +9.8% | 0.00% | +33.3% |
Q3 2022 | $2,132,000 | +20.3% | 108,102 | +18.9% | 0.00% | 0.0% |
Q2 2022 | $1,772,000 | -8.5% | 90,903 | +19.7% | 0.00% | +50.0% |
Q1 2022 | $1,937,000 | -3.9% | 75,943 | -5.1% | 0.00% | 0.0% |
Q4 2021 | $2,015,000 | -9.4% | 80,056 | -0.9% | 0.00% | -33.3% |
Q3 2021 | $2,223,000 | -10.4% | 80,810 | +3.3% | 0.00% | 0.0% |
Q2 2021 | $2,482,000 | +18.1% | 78,201 | +70.8% | 0.00% | 0.0% |
Q1 2021 | $2,101,000 | +14.6% | 45,794 | -1.2% | 0.00% | 0.0% |
Q4 2020 | $1,834,000 | +26.9% | 46,327 | +11.6% | 0.00% | +50.0% |
Q3 2020 | $1,445,000 | +143.3% | 41,528 | +120.8% | 0.00% | +100.0% |
Q2 2020 | $594,000 | +89.2% | 18,809 | +31.3% | 0.00% | 0.0% |
Q1 2020 | $314,000 | – | 14,322 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |